Skip to main content
Smart Investors Daily
WA

NASDAQ · WAVS

Western Acquisition Ventures Corp.

Financial Services · Shell Companies

$12.00

Up+$2.00 (+20.00%)

Updated Aug 17, 2026, 6:22 AM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
41.1M
P/E ratio
-1.36
Dividend yield
0.00%
52-week range
— – —
Volume
1.75K
Avg. volume
3.04K

Price performance

WAVS price history

1M range · 0 trading sessions · Daily adjusted prices

WAVS does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest WAVS news

The latest Smart Investors Daily articles mentioning WAVS.

WAVS research

Overview

Company profile and research snapshot.

Company profile

Western Acquisition Ventures Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target businesses. It focuses on businesses operating in the infrastructure and environmental services; health, wellness, and food sustainability; financial technology and financial services; enterprise software and SaaS; and leisure and hospitality industries. The company was incorporated in 2021 and is based in New York, New York.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Jul 17, 2023

Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket

Gainers Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares surged 43.9% to $9.03 in pre-market trading after the company presented topline results from Phase 1 study of ACU193 for early Alzheimer's disease at the Alzheimer's Association International Conference 2023. PainReform Ltd. (NASDAQ: PRFX) shares gained 29.5% to $10.49 in pre-market trading. PainReform reported pricing of $1.5 million concurrent registered direct offering and private placement. Nova LifeStyle, Inc. (NASDAQ: NVFY) rose 27.7% to $2.81 in pre-market trading after declining over 6% on Friday. argenx SE (NASDAQ: ARGX) shares rose 24.3% to $471.47 in pre-market trading after reporting topline data from ADHERE study of VYVGART hytrulo in patients with chronic inflammatory demyelinating polyneuropathy. AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 23.3% to $0.6801 in pre-market trading. BridgeBio Pharma, Inc. (NASDAQ: BBIO) gained 20.5% to $21.98 in pre-market trading after the company's Phase 3 ATTRibute-CM study of acoramidis for transthyretin amyloid ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.